Cargando…
RT-qPCR Testing of SARS-CoV-2: A Primer
Testing for the presence of coronavirus is an essential diagnostic tool for monitoring and managing the current COVID-19 pandemic. The only reliable test in current use for testing acute infection targets the genome of SARS-CoV-2, and the most widely used method is quantitative fluorescence-based re...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215906/ https://www.ncbi.nlm.nih.gov/pubmed/32344568 http://dx.doi.org/10.3390/ijms21083004 |
_version_ | 1783532296974893056 |
---|---|
author | Bustin, Stephen A. Nolan, Tania |
author_facet | Bustin, Stephen A. Nolan, Tania |
author_sort | Bustin, Stephen A. |
collection | PubMed |
description | Testing for the presence of coronavirus is an essential diagnostic tool for monitoring and managing the current COVID-19 pandemic. The only reliable test in current use for testing acute infection targets the genome of SARS-CoV-2, and the most widely used method is quantitative fluorescence-based reverse transcription polymerase chain reaction (RT-qPCR). Despite its ubiquity, there is a significant amount of uncertainty about how this test works, potential throughput and reliability. This has resulted in widespread misrepresentation of the problems faced using this test during the current COVID-19 epidemic. This primer provides simple, straightforward and impartial information about RT-qPCR. |
format | Online Article Text |
id | pubmed-7215906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72159062020-05-22 RT-qPCR Testing of SARS-CoV-2: A Primer Bustin, Stephen A. Nolan, Tania Int J Mol Sci Commentary Testing for the presence of coronavirus is an essential diagnostic tool for monitoring and managing the current COVID-19 pandemic. The only reliable test in current use for testing acute infection targets the genome of SARS-CoV-2, and the most widely used method is quantitative fluorescence-based reverse transcription polymerase chain reaction (RT-qPCR). Despite its ubiquity, there is a significant amount of uncertainty about how this test works, potential throughput and reliability. This has resulted in widespread misrepresentation of the problems faced using this test during the current COVID-19 epidemic. This primer provides simple, straightforward and impartial information about RT-qPCR. MDPI 2020-04-24 /pmc/articles/PMC7215906/ /pubmed/32344568 http://dx.doi.org/10.3390/ijms21083004 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Bustin, Stephen A. Nolan, Tania RT-qPCR Testing of SARS-CoV-2: A Primer |
title | RT-qPCR Testing of SARS-CoV-2: A Primer |
title_full | RT-qPCR Testing of SARS-CoV-2: A Primer |
title_fullStr | RT-qPCR Testing of SARS-CoV-2: A Primer |
title_full_unstemmed | RT-qPCR Testing of SARS-CoV-2: A Primer |
title_short | RT-qPCR Testing of SARS-CoV-2: A Primer |
title_sort | rt-qpcr testing of sars-cov-2: a primer |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215906/ https://www.ncbi.nlm.nih.gov/pubmed/32344568 http://dx.doi.org/10.3390/ijms21083004 |
work_keys_str_mv | AT bustinstephena rtqpcrtestingofsarscov2aprimer AT nolantania rtqpcrtestingofsarscov2aprimer |